InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,505.00
(
-0.71%
)
US TECH 100
19,000.00
(
-0.94%
)
Dow Jones
40,287.53
(
-0.93%
)
Brent Oil
81.88
(
0.00%
)
Bitcoin
66,888.42
(
-0.42%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

micanwait

Send PM Follow Ignore
Followers 6
Posts 718
Boards Moderated 0
Alias Born 06/22/2011

micanwait

Re: BTH post# 19659

Tuesday, 06/12/2012 6:31:43 AM

Tuesday, June 12, 2012 6:31:43 AM

Post# of 80490
Isn't that the point? If Pona is better than Tasigna why not grab it?

I have next to zero medical knowledge, but it would seem to me that the holy grail of oncology is a drug that does not permit drug resistance through mutation. Why waste gazillions of dollars on a drug that may not address all mutations, when the Ariad lab is skilled at producing a drug that does?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up